Literature DB >> 8141573

Antimicrobial susceptibilities of Neisseria gonorrhoeae strains representing five distinct resistance phenotypes.

R J Rice1, J S Knapp.   

Abstract

The susceptibilities of 109 strains of Neisseria gonorrhoeae to penicillin G, tetracycline, amoxicillin-clavulanic acid, cefotetan, cefoxitin, ceftriaxone, ciprofloxacin, and fleroxacin were determined. The activities of cefmetazole, cefuroxime, cefixime, and ofloxacin were also determined against 62 of these strains. Strains represented penicillin-susceptible (Pen(s)) N. gonorrhoeae; penicillinase-producing N. gonorrhoeae (PPNG) possessing 2.9-, 3.05-, 3.2-, or 4.4-MDa beta-lactamase plasmids; strains with high-level, plasmid-mediated tetracycline resistance (TRNG); strains with plasmid-mediated resistance to penicillin and tetracycline; and strains with chromosomally mediated resistance to penicillin and tetracycline (CMRNG). Ceftriaxone, cefixime, and ciprofloxacin were the most active agents tested against all strains. Pen(s), TRNG, and PPNG strains possessing a 3.2-MDa beta-lactamase plasmid were more susceptible to amoxicillin-clavulanic acid, extended- and broad-spectrum cephalosporins, and quinolones than were either PPNG strains possessing a 2.9-, a 3.05-, or a 4.4-MDa beta-lactamase plasmid or CMRNG strains.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8141573      PMCID: PMC284415          DOI: 10.1128/AAC.38.1.155

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  9 in total

1.  Evaluation of the standardized disk diffusion and agar dilution antibiotic susceptibility test methods by using strains of Neisseria gonorrhoeae from the United States and Southeast Asia.

Authors:  S D Putnam; B S Lavin; J R Stone; E C Oldfield; D G Hooper
Journal:  J Clin Microbiol       Date:  1992-04       Impact factor: 5.948

2.  National surveillance of antimicrobial resistance in Neisseria gonorrhoeae. The Gonococcal Isolate Surveillance Project.

Authors:  S K Schwarcz; J M Zenilman; D Schnell; J S Knapp; E W Hook; S Thompson; F N Judson; K K Holmes
Journal:  JAMA       Date:  1990-09-19       Impact factor: 56.272

3.  Penicillinase-producing Neisseria gonorrhoeae in Dade County, Florida: phenotypic characterization of isolates from 1983, 1984, and 1986.

Authors:  J M Zenilman; W L Whittington; D Frazier; R J Rice; J S Knapp
Journal:  Sex Transm Dis       Date:  1988 Jul-Sep       Impact factor: 2.830

4.  Epidemiology of gonorrhea: distribution and temporal changes in auxotype/serovar classes of Neisseria gonorrhoeae.

Authors:  J S Knapp; K K Holmes; P Bonin; E W Hook
Journal:  Sex Transm Dis       Date:  1987 Jan-Mar       Impact factor: 2.830

5.  A comparison of single-dose cefixime with ceftriaxone as treatment for uncomplicated gonorrhea. The Gonorrhea Treatment Study Group.

Authors:  H H Handsfield; W M McCormack; E W Hook; J M Douglas; J M Covino; M S Verdon; C A Reichart; J M Ehret
Journal:  N Engl J Med       Date:  1991-11-07       Impact factor: 91.245

6.  Sentinel surveillance for antimicrobial resistance in Neisseria gonorrhoeae--United States, 1988-1991. The Gonococcal Isolate Surveillance Project Study Group.

Authors:  R J Gorwitz; A K Nakashima; J S Moran; J S Knapp
Journal:  MMWR CDC Surveill Summ       Date:  1993-08-13

Review 7.  Trends in resistance of Neisseria gonorrhoeae to antimicrobial agents in the United States.

Authors:  W L Whittington; J S Knapp
Journal:  Sex Transm Dis       Date:  1988 Oct-Dec       Impact factor: 2.830

8.  Ceftriaxone for treatment of uncomplicated gonorrhea: routine use of a single 125-mg dose in a sexually transmitted disease clinic.

Authors:  H H Handsfield; E W Hook
Journal:  Sex Transm Dis       Date:  1987 Oct-Dec       Impact factor: 2.830

9.  Antibiotic susceptibility survey of Neisseria gonorrhoeae in Thailand.

Authors:  T E Clendennen; P Echeverria; S Saengeur; E S Kees; J W Boslego; F S Wignall
Journal:  Antimicrob Agents Chemother       Date:  1992-08       Impact factor: 5.191

  9 in total
  12 in total

1.  Identification of novel mutation patterns in the parC gene of ciprofloxacin-resistant isolates of Neisseria gonorrhoeae.

Authors:  D L Trees; A L Sandul; W L Whittington; J S Knapp
Journal:  Antimicrob Agents Chemother       Date:  1998-08       Impact factor: 5.191

2.  Antimicrobial susceptibility of Neisseria gonorrhoeae isolated in Bangladesh (1997 to 1999): rapid shift to fluoroquinolone resistance.

Authors:  Motiur Rahman; Zafar Sultan; Shirajum Monira; Ashraful Alam; Khairun Nessa; Sonia Islam; Shamsun Nahar; Shahnewaz Alam Khan; Jozef Bogaerts; Nazrul Islam; John Albert
Journal:  J Clin Microbiol       Date:  2002-06       Impact factor: 5.948

3.  In vitro activity of a new fluoroquinolone, CP-99,219, against strains of Neisseria gonorrhoeae.

Authors:  J S Knapp; S W Neal; M C Parekh; R J Rice
Journal:  Antimicrob Agents Chemother       Date:  1995-04       Impact factor: 5.191

4.  Persistence of Neisseria gonorrhoeae strains with decreased susceptibilities to ciprofloxacin and ofloxacin in Cleveland, Ohio, from 1992 through 1993.

Authors:  J S Knapp; J A Washington; L J Doyle; S W Neal; M C Parekh; R J Rice
Journal:  Antimicrob Agents Chemother       Date:  1994-09       Impact factor: 5.191

5.  Use of the neisserial lipoprotein (Lip) for subtyping Neisseria gonorrhoeae.

Authors:  D L Trees; A J Schultz; J S Knapp
Journal:  J Clin Microbiol       Date:  2000-08       Impact factor: 5.948

6.  Monitoring antimicrobial susceptibility of Neisseria gonorrhoeae isolated from Bangladesh during 1997-2006: emergence and pattern of drug-resistant isolates.

Authors:  Monir Uddin Ahmed; Faisal Arif Hasan Chawdhury; Maqsud Hossain; Syed Zafar Sultan; Mansur Alam; Gazi Salahuddin; Ashraful Alam; Khairun Nessa; Shamsun Nahar; Anadil Alam; Motiur Rahman
Journal:  J Health Popul Nutr       Date:  2010-10       Impact factor: 2.000

7.  Susceptibility of Neisseria gonorrhoeae associated with pelvic inflammatory disease to cefoxitin, ceftriaxone, clindamycin, gentamicin, doxycycline, azithromycin, and other antimicrobial agents.

Authors:  R J Rice; J S Knapp
Journal:  Antimicrob Agents Chemother       Date:  1994-07       Impact factor: 5.191

8.  Evaluation of nucleic acid-based test (PACE 2C) for simultaneous detection of Chlamydia trachomatis and Neisseria gonorrhoeae in endocervical specimens.

Authors:  P C Iwen; R A Walker; K L Warren; D M Kelly; S H Hinrichs; J Linder
Journal:  J Clin Microbiol       Date:  1995-10       Impact factor: 5.948

9.  Proposed criteria for interpretation of susceptibilities of strains of Neisseria gonorrhoeae to ciprofloxacin, ofloxacin, enoxacin, lomefloxacin, and norfloxacin.

Authors:  J S Knapp; J A Hale; S W Neal; K Wintersheid; R J Rice; W L Whittington
Journal:  Antimicrob Agents Chemother       Date:  1995-11       Impact factor: 5.191

Review 10.  Quinolones in sexually transmitted diseases. Global experience.

Authors:  G L Ridgway
Journal:  Drugs       Date:  1995       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.